HomeFactor Ix Complex ConcentratesFactor Ix Complex Concentrates + Concizumab

Does Factor Ix Complex Concentrates Interact with Concizumab?

Factor Ix Complex Concentrates and Concizumab have a major drug interaction according to U.S. FDA drug labeling data. High and/or frequent doses increase risk of thromboembolism. Maximum dose of 100 units/kg within 24 hours recommended. Additive and synergistic increase in thrombin peak observed. The mechanism involves additive and synergistic increase in thrombin generation. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Major
Concizumab Class
Tissue Factor Pathway Inhibitor Antagonist
Management
Close medical supervision required
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Factor Ix Complex Concentrates and Concizumab occurs because additive and synergistic increase in thrombin generation. Clinically, this means high and/or frequent doses increase risk of thromboembolism. maximum dose of 100 units/kg within 24 hours recommended. additive and synergistic increase in thrombin peak observed. This is classified as a major interaction, meaning it could cause serious harm if not properly managed. Your healthcare provider may need to adjust dosages, substitute one medication, or increase monitoring frequency.

What To Tell Your Doctor or Pharmacist

If you are taking Factor Ix Complex Concentrates and your doctor is considering prescribing Concizumab (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask how frequently you should be monitored while these are co-prescribed
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Factor Ix Complex Concentrates(Profilnine)+💊 Concizumab(Alhemo)

Severity & Interaction Details

⚠️
major
Use with caution — major interaction
Serious risk of clinically significant harm. Generally avoid; if used, monitor closely.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Tissue Factor Pathway Inhibitor Antagonist
Source
NLP:concizumab

What this means in plain English

High and/or frequent doses increase risk of thromboembolism. Maximum dose of 100 units/kg within 24 hours recommended. Additive and synergistic increase in thrombin peak observed.

About Factor Ix Complex Concentrates and Concizumab

Concizumab is a Tissue Factor Pathway Inhibitor Antagonist. You may recognize them by the brand names Profilnine and Alhemo. Concizumab is given by injection under the skin.

What the FDA label says

"Additive and synergistic increase in thrombin generation"

📖 Source: NLP:concizumab

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Factor Ix Complex Concentrates and Concizumab against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.